41 – 50 of 114
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Cysteinyl leukotrienes and their receptors: Bridging inflammation and colorectal cancer.
- Contribution to journal › Article
-
Mark
The inflammatory mediator leukotriene D4 induces subcellular β-catenin translocation and migration of colon cancer cells.
- Contribution to journal › Article
-
Mark
Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression.
- Contribution to journal › Article
-
Mark
Loss-of-function mutations in SLC30A8 protect against type 2 diabetes.
- Contribution to journal › Article
-
Mark
The role of CysLT1R in animal models of colorectal cancer
- Thesis › Doctoral thesis (compilation)
- 2013
-
Mark
CYLD Enhances Severe Listeriosis by Impairing IL-6/STAT3-Dependent Fibrin Production
- Contribution to journal › Article
-
Mark
The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.
- Contribution to journal › Article
-
Mark
CysLT1R Antagonists Inhibit Tumor Growth in a Xenograft Model of Colon Cancer.
- Contribution to journal › Article
-
Mark
The cysteinyl leukotriene 2 receptor contributes to all-trans retinoic acid-induced differentiation of colon cancer cells
- Contribution to journal › Article
-
Mark
Nuclear expression of Glycogen synthase kinase-3 beta and lack of membranous beta-catenin is correlated with poor survival in colon cancer
- Contribution to journal › Article
